secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001628280-23-015988
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience Q2 revenue record $60.2M (+25% YoY); cuts 270 jobs (~25% workforce)
--------------------------------------------------------------------------------

- Revenue $60.2M, up 25% YoY; orders $64.2M, up 17% YoY.
- Net loss $59.2M ($1.04 EPS) vs $60.7M ($1.13) prior year.
- Workforce reduction of ~270 employees (~25%); expects pre-tax charges $9-11M.
- Withdrew prior FY2024 guidance; provided limited updated guidance focused on cost reduction.
- Cash $387.7M; shipped to 2,100 customers, 152k genes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000162828023015988/0001628280-23-015988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000162828023015988/twist-20230503.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-015988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer